Rapid Readout: Clinical Updates in Multiple Sclerosis From CMSC 2020 - Episode 1
“We’re going to continue to learn more and more, as more studies are done. In our annual meeting this year, there was sort of a peppering of many of those topics, and I encourage people to take a look because I certainly learned a lot watching some of these presentations.”
In late May, the Consortium of Multiple Sclerosis Centers (CMSC) launched its annual meeting in a virtual format, offering 4 days’ worth of events and presentations covering a plethora of data and information surrounding the treatment and management of multiple sclerosis (MS) and related diseases. Despite it being an unprecedented year, CMSC 2020 continued to offer a focus on multidisciplinary care within these patient populations.
In a conversation with NeurologyLive, Scott Newsome, DO, MSCS, FAAN, president, CMSC, and associate professor of neurology, Johns Hopkins Medicine, offered his perspective on this year’s meeting and its topics. He noted that the presentations ranged from updates on the emerging therapies in MS and diseases like neuromyelitis optic spectrum disorder (NMOSD), as well as the latest news on the complementary therapy front.
Newsome also discussed in further detail what the most recent data on disease-modifying therapies and non-pharmacologic interventions suggest about the importance of taking a more holistic approach to the management of patients with MS.